Dr. Mel Andersen to Speak at 2015 CropLife America Spring Conference http://www.thehamner.org/news-events/entry/mel-andersen-to-speak-at-2015-croplife-america-spring-conference Dr. Barbara Wetmore To Present at ILSI-Brazil Annual Meeting http://www.thehamner.org/news-events/entry/barbara-wetmore-to-present-at-ilsi-brazil-annual-meeting Hamner Awards at the 2015 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/hamner-awards-at-the-2015-society-of-toxicology-annual-meeting Scientists At The Hamner Institutes Receive Ten Awards From Society of Toxicology RESEARCH TRIANGLE PARK, N.C. – April 9, 2015 – The Hamner Institutes for Health Sciences (http://www.thehamner.org) has announced that its scientists have been recognized with ten awards from the Society of Toxicology (SOT), a professional organization committed to creating a safer and healthier world by advancing the science of toxicology, at their 54th Annual Meeting that was held March 22-26 in San Diego, California. The award honors follow an impressive presence at the meeting that consisted of over 45 presentations by Hamner scientists. http://www.thehamner.org/news-events/entry/scientists-at-the-hamner-institutes-receive-ten-awards-from-society-of-toxi The Hamner Releases DILIsym® v4A and MITOsym® v2B RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences (www.thehamner.org) announces the release of DILIsym® v4A and MITOsym® v2B. DILIsym® and MITOsym® software are developed and released as part of the DILI-sim Initiative (www.dilisym.com), an effort to develop a mathematical, mechanistic model of drug-induced liver injury chaired by Dr. Paul B. Watkins. DILIsym® v4A and MITOsym® v2B were made available to all DILI-sim Initiative industry members as of March 31, 2015. http://www.thehamner.org/news-events/entry/the-hamner-releases-dilisym-v4a-and-mitosym-v2b Certara Supported Risk Assessment Research Wins Outstanding Paper Award Press release from Certara on Hamner Senior Research Investigator Dr. Barbara Wetmore's award-winning paper, which was recognized at the 2015 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/certara-supported-risk-assessment-research-wins-outstanding-paper-award Simcyp used in award winning toxicological research http://www.thehamner.org/news-events/entry/simcyp-used-in-award-winning-toxicological-research Hamner Scientists at 2015 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/hamner-scientists-at-2015-society-of-toxicology-annual-meeting Personalized Toxicology: A New Paradigm for Chemical Risk Assessment http://www.thehamner.org/news-events/entry/personalized-toxicology-a-new-paradigm-for-chemical-risk-assessment IDSS Scientists to Speak at DILI Conference XV http://www.thehamner.org/news-events/entry/idss-scientists-to-speak-at-dili-conference-xv The Hamner at the 2015 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/the-hamner-at-the-2015-society-of-toxicology-annual-meeting Dr. Jenny Pedersen to Receive Best Thesis Award http://www.thehamner.org/news-events/entry/jenny-pedersen-to-receive-best-thesis-award Linking high-throughput data to human exposures http://www.thehamner.org/news-events/entry/linking-high-throughput-data-to-human-exposures Dr. Barbara Wetmore Elected to Be New Vice President of SOT Specialty Section http://www.thehamner.org/news-events/entry/barbara-wetmore-elected-to-be-new-vice-president-of-sot-specialty-secti Astellas Pharma Joins The DILI-sim Initiative Japan-based pharma becomes newest member company of The DILI-sim Consortium http://www.thehamner.org/news-events/entry/astellas-pharma-joins-the-dili-sim-initiative The Hamner Announces Formation of The Comprehensive Center for Liver and Metabolic Disease Research RESEARCH TRIANGLE PARK, N.C. – The Hamner Institutes for Health Sciences (The Hamner) has announced the formation of the Comprehensive Center for Liver and Metabolic Disease Research (CCLMDR), a pre-competitive, collaborative partnership between The Hamner and a diverse set of stakeholders across industry and academia to pool resources and co-develop platforms focused on liver and metabolic disease research. The CCLMDR’s vision is to be the recognized global leader and ultimate collaborative research resource for the development of strategies and next-generation technologies aimed at conquering liver and liver-related metabolic diseases. The Steering Committee for the CCLMDR is headed by Dr. Paul Watkins, director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, and Dr. Edward LeCluyse, associate investigator at The Hamner. http://www.thehamner.org/news-events/entry/the-hamner-announces-formation-of-the-comprehensive-center-for-liver-and-me Society of Toxicology Announces 2015 Best Toxicological Paper Award Hamner scientists honored as co-authors on top publication http://www.thehamner.org/news-events/entry/society-of-toxicology-announces-2015-best-toxicological-paper-award Top 10 Innovations 2014 Hamner scientist Dr. Ed LeCluyse is quoted in an article from "The Scientist" detailing their picks for the Top 10 Innovations of 2014. http://www.thehamner.org/news-events/entry/top-10-innovations-2014 Watkins Co-Authors Drug Safety Supplement The Hamner Institutes for Health Sciences and the European Innovative Medicines Initiative (IMI) sponsored a 2012 workshop in Boston that included academic and industry leaders and also regulators from FDA, Health Canada, European Medicines Agency, and regulators from Japan and China. The outcome of this workshop was six white papers to be published together in December 2014 in the journal “Drug Safety”. http://www.thehamner.org/news-events/entry/watkins-co-authors-drug-safety-supplement Weaving a Stronger Drug Safety Net http://www.thehamner.org/news-events/entry/weaving-a-stronger-drug-safety-net Watkins Receives AICPT Rawls-Palmer Progress in Medicine Award Hamner-UNC Institute for Drug Safety Sciences director wins prestigious award for multiple contributions to the field of clinical pharmacology. http://www.thehamner.org/news-events/entry/watkins-receives-aicpt-rawls-palmer-progress-in-medicine-award Internationally recognized health scientist Dr. Harvey Clewell renews association with ENVIRON Arlington, VA/October 29, 2014 -ENVIRON, an international environmental, health, safety and sustainability consultancy, announced today that Dr. Harvey Clewell III has rejoined the firm as a Principal Consultant and will work closely with senior professionals in ENVIRON’s Health Sciences practice. Dr. Clewell will also continue to serve at The Hamner Institutes for Health Sciences (The Hamner) in Research Triangle Park, North Carolina, where he is Director, Center for Human Health Assessment. http://www.thehamner.org/news-events/entry/internationally-recognized-health-scientist-harvey-clewell-ENVIRON Hamner Co-Hosts First Systems Toxicology Workshop in China http://www.thehamner.org/news-events/entry/hamner-co-hosts-first-systems-toxicology-workshop-in-china Dr. Paul Watkins to Speak at 2014 ITMAT Symposium http://www.thehamner.org/news-events/entry/paul-watkins-to-speak-at-2014-itmat-symposium Big Pharma: More public-private partnerships needed for Ebola vaccine development http://www.thehamner.org/news-events/entry/big-pharma-more-public-private-partnerships-needed-for-ebola-vaccine-develo Pharmacy school researchers studying deadly diabetes drug http://www.thehamner.org/news-events/entry/pharmacy-school-researchers-studying-deadly-diabetes-drug Why a deadly drug didn’t hurt lab rat livers http://www.thehamner.org/news-events/entry/why-a-deadly-drug-didnt-hurt-lab-rat-livers The Hamner to Host Agilent’s Environmental Exposure Science Symposium http://www.thehamner.org/news-events/entry/the-hamner-to-host-agilents-environmental-exposure-science-symposium Hamner’s DILIsym® Solves Mystery of Failed Diabetes Drug Researchers at the UNC Eshelman School of Pharmacy show that the DILIsym® software can be used to predict risk of drug-induced liver injury http://www.thehamner.org/news-events/entry/hamners-dilisym-solves-mystery-of-failed-diabetes-drug A Framework For Visualizing Toxicity Pathways The Hamner computational biology team is developing new tools to make genomic data more intuitive. http://www.thehamner.org/news-events/entry/a-framework-for-visualizing-toxicity-pathways Dr. Ed LeCluyse to Present at Land O’Lakes DMPK Conference http://www.thehamner.org/news-events/entry/ed-lecluyse-to-present-at-land-olakes-dmpk-conference 1st Annual Conference for the Society of Biomolecular Imaging and Informatics (SBI2) http://www.thehamner.org/news-events/entry/1st-annual-conference-for-the-society-of-biomolecular-imaging-and-informati The Hamner Releases DILIsym® v3B RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences (www.thehamner.org) announces the release of DILIsym® v3B. DILIsym® software is developed and released as part of the DILI-sim Initiative (www.dilisym.com), an effort to develop a mathematical, mechanistic model of drug-induced liver injury chaired by Dr. Paul B. Watkins. DILIsym® v3B was made available to all DILI-sim Initiative industry members as of August 26, 2014. http://www.thehamner.org/news-events/entry/the-hamner-releases-dilisym-v3b Expert Insights on In Vitro Alternatives for Drug and Chemical Toxicity Testing Hamner CSO Dr. Melvin Andersen's recent commentary published in the new journal, Applied In Vitro Toxicology http://www.thehamner.org/news-events/entry/expert-insights-on-in-vitro-alternatives-for-drug-and-chemical-toxicity-tes Dr. Mel Andersen to Give Plenary Lecture at HESI Genetic Toxicology Workshop http://www.thehamner.org/news-events/entry/mel-andersen-to-give-plenary-lecture-at-hesi-genetic-toxicology-worksho The Hamner on UNC-TV: The Liver Takes It All http://www.thehamner.org/news-events/entry/the-hamner-on-unc-tv-the-liver-takes-it-all Hamner Scientists at 2014 ICCA-LRI and JRC Meeting http://www.thehamner.org/news-events/entry/hamner-scientists-at-2014-icca-lri-and-jrc-meeting The Hamner on UNC-TV: The 99% Solution http://www.thehamner.org/news-events/entry/the-hamner-on-unc-tv-99-solution Dr. Ed LeCluyse to Speak at Gordon Research Conference http://www.thehamner.org/news-events/entry/ed-lecluyse-to-speak-at-gordon-research-conference Dr. Merrie Mosedale to Speak at 13th World Pharma Congress http://www.thehamner.org/news-events/entry/merrie-mosedale-to-speak-at-13th-world-pharma-congress Dr. Brett Howell to Speak at 20th International Symposium on Microsomes and Drug Oxidations http://www.thehamner.org/news-events/entry/brett-howell-to-speak-at-20th-international-symposium-on-microsomes-and Dr. Melvin Andersen to Give Keynote Lecture at NC3Rs Workshop http://www.thehamner.org/news-events/entry/melvin-andersen-to-give-keynote-lecture-at-nc3rs-workshop IDSS Scientists to Present at DIA Meeting http://www.thehamner.org/news-events/entry/idss-scientists-to-present-at-dia-meeting Dr. Melvin Andersen to Present at US EPA Formaldehyde Workshop http://www.thehamner.org/news-events/entry/melvin-andersen-to-present-at-us-epa-formaldehyde-workshop Scientists At The Hamner Institutes For Health Sciences Receive 6 Awards From Society Of Toxicology RESEARCH TRIANGLE PARK, N.C. – April 8, 2014 – The Hamner Institutes for Health Sciences (http://www.thehamner.org) has announced that its scientists have been recognized with six awards from the Society of Toxicology (SOT), a professional organization committed to creating a safer and healthier world by advancing the science of toxicology, at their 53rd Annual Meeting that was held March 23-27 in Phoenix, Arizona. The award honors follow an impressive presence at the meeting that consisted of over 40 presentations by Hamner scientists. http://www.thehamner.org/news-events/entry/scientists-at-the-hamner-institutes-for-health-sciences-receive-6-awards-fr Hamner Awards at the 2014 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/hamner-awards-at-the-2014-society-of-toxicology-annual-meeting Takeda Joins The DILI-sim Initiative RESEARCH TRIANGLE PARK, N.C. – April 2, 2014 – The Hamner Institutes for Health Sciences (The Hamner) has announced that Takeda Pharmaceuticals International, Inc. (Takeda) has agreed to become the newest member of The DILI-sim Initiative. Having sustained a long corporate history of more than 230 years, Takeda conducts activities according to the corporate mission to “strive towards better health for people worldwide through leading innovation in medicine.” Takeda becomes the fourteenth member of the DILI-sim consortium, joining current members AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Gilead, GlaxoSmithKline, Janssen Research & Development, LLC, Merck, Mitsubishi Tanabe Pharma, Otsuka, Pfizer and Sanofi. http://www.thehamner.org/news-events/entry/takeda-joins-the-dili-sim-initiative Getting More from ADME-Tox Assays http://www.thehamner.org/news-events/entry/getting-more-from-adme-tox-assays Hamner Scientists at Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/hamner-scientists-at-society-of-toxicology-annual-meeting Abbvie Joins The DILI-sim Initiative RESEARCH TRIANGLE PARK, N.C. – March 21, 2014 – The Hamner Institutes for Health Sciences (The Hamner) has announced that AbbVie Inc. has agreed to become the newest member of The DILI-sim Initiative. Founded in 2013, AbbVie is a research-based global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie becomes the thirteenth member of the DILI-sim consortium, joining current members Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Gilead, GlaxoSmithKline, Janssen Research & Development, LLC, Merck, Mitsubishi Tanabe Pharma, Otsuka, Pfizer and Sanofi. http://www.thehamner.org/news-events/entry/abbvie-joins-the-dili-sim-initiative IDSS Scientists to Speak at AASLD DILI Conference http://www.thehamner.org/news-events/entry/idss-scientists-to-speak-at-aasld-dili-conference Alexandria Real Estate envisions ‘convergence cluster’ on RTP site http://www.thehamner.org/news-events/entry/alexandria-real-estate-envisions-convergence-cluster-on-rtp-site The Hamner at the 2014 Society of Toxicology Annual Meeting http://www.thehamner.org/news-events/entry/the-hamner-at-the-2014-society-of-toxicology-annual-meeting Cellular Dynamics International Reports Fourth Quarter and Fiscal Year 2013 Financial Results http://www.thehamner.org/news-events/entry/cellular-dynamics-international-reports-fourth-quarter-and-fiscal-year-2013 The Hamner Releases DILIsym® v3A and MITOsym™ v2A RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences (www.thehamner.org) announces the release of DILIsym® v3A and MITOsym™ v2A. DILIsym® and MITOsym™ software are developed and released as part of the DILI-sim Initiative (www.dilisym.com), an effort to develop a mathematical, mechanistic model of drug-induced liver injury chaired by Dr. Paul B. Watkins. DILIsym® v3A and MITOsym™ v2A were made available to all DILI-sim Initiative industry members as of March 6, 2014. http://www.thehamner.org/news-events/entry/the-hamner-releases-dilisym-v3a-and-mitosym-v2a Otsuka Joins The DILI-sim Initiative RESEARCH TRIANGLE PARK, N.C. – February 19, 2014 – The Hamner Institutes for Health Sciences (The Hamner) has announced that Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) has agreed to become the newest member of The DILI-sim Initiative. Established in 2007, OPDC is a part of the Japan-based Otsuka Group (Otsuka) responsible for the research and clinical development of healthcare products. Otsuka becomes the twelfth member of the DILI-sim consortium, joining current members Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Gilead, GlaxoSmithKline, Janssen Research & Development, LLC, Merck, Mitsubishi Tanabe Pharma, Pfizer and Sanofi. http://www.thehamner.org/news-events/entry/otsuka-joins-the-dili-sim-initiative Toward Three-Dimensional Liver Bioassays http://www.thehamner.org/news-events/entry/toward-three-dimensional-liver-bioassays Striving for 21st century toxicology http://www.thehamner.org/news-events/entry/striving-for-21st-century-toxicology The Hamner and EURL ECVAM Publish Report on How Toxicity Pathway Concepts Can Be Applied The US National Research Council's report (2007), "Toxicity Testing in the 21st Century: A Vision and Strategy”, represented a step-change in thinking surrounding the safety assessment of environmental chemicals. The take-home message was that by understanding toxicity in terms of Toxicity Pathways, we'll be able to use intelligent combinations of computational and in vitro methods to assess the potential hazard and risk that a chemical may pose to humans and the environment, without resorting to animal testing. Shifting to this new paradigm promises more efficient, comprehensive and cost effective testing strategies for every chemical in commerce and will provide a convincing scientific basis to move away from animal testing. But 7 years on from the publication of the NRC landmark report, much still needs to be done to translate Toxicity Pathway concepts into safety assessment practice. http://www.thehamner.org/news-events/entry/the-hamner-and-eurl-ecvam-publish-report-on-how-toxicity-pathway-concepts-c Joe Trask to Lead SBI2 West Coast Regional Meeting http://www.thehamner.org/news-events/entry/joe-trask-to-lead-sbi2-west-coast-regional-meeting Joe Trask to Present at 2014 SLAS Conference http://www.thehamner.org/news-events/entry/joe-trask-to-present-at-2014-slas-conference Agilent Technologies Thought Leader Award Supports Dr. Paul Watkins, Hamner-UNC IDSS http://www.thehamner.org/news-events/entry/agilent-technologies-thought-leader-award-supports-paul-watkins-hamner Agilent Technologies Thought Leader Award Supports Dr. Paul Watkins Agilent Technologies Inc. (NYSE: A) today announced that Dr. Paul B. Watkins, international drug safety expert and director of the Hamner-University of North Carolina Institute for Drug Safety Sciences, has received an Agilent Thought Leader Award in recognition of his ongoing work developing integrated methods to predict drug-induced liver injury (DILI). http://www.thehamner.org/news-events/entry/agilent-technologies-thought-leader-award-supports-paul-watkins Joe Trask to Lead SBI2 Midwest Regional Meeting http://www.thehamner.org/news-events/entry/joe-trask-to-lead-sbi2-midwest-regional-meeting The Hamner Institutes and Cellular Dynamics Announce Collaboration - News Clips Media coverage of The Hamner's joint release with Cellular Dynamics on December 9, 2013 to anoounce a collaboration to develop in vitro assays using human iPS cell-derived hepatocytes. http://www.thehamner.org/news-events/entry/the-hamner-institutes-and-cellular-dynamics-announce-collaboration-news-cli The Hamner Institutes and Cellular Dynamics Announce Collaboration to Develop In Vitro Assays RESEARCH TRIANGLE PARK, N.C., and MADISON, WIS., December 9, 2013 – The Hamner Institutes for Health Sciences today announced a collaborative agreement with Cellular Dynamics International (CDI) to develop predictive in vitro screening assays for chemical, environmental and pharmaceutical toxicology assessments that utilize CDI’s human induced pluripotent stem (iPS) cell-derived hepatocytes. http://www.thehamner.org/news-events/entry/the-hamner-institutes-and-cellular-dynamics-announce-collaboration-to-devel Dr. Melvin Andersen to Speak at Chinese SOT http://www.thehamner.org/news-events/entry/melvin-andersen-to-speak-at-chinese-sot IDSS Scientists to Present at DIA Program http://www.thehamner.org/news-events/entry/idss-scientists-to-present-at-dia-program Dr. Paul Watkins to Present at Pharmacovigilance Expert Workshop http://www.thehamner.org/news-events/entry/paul-watkins-to-present-at-pharmacovigilance-expert-workshop Dr. Paul Watkins to Present at 10th International ISSX Meeting http://www.thehamner.org/news-events/entry/paul-watkins-to-present-at-10th-international-issx-meeting Dr. Paul Watkins to Speak at FDA-C-Path-ISoP Workshop http://www.thehamner.org/news-events/entry/paul-watkins-to-speak-at-fda-c-path-isop-workshop Dr. Paul Watkins to Speak at ACS National Meeting http://www.thehamner.org/news-events/entry/paul-watkins-to-speak-at-acs-national-meeting Better tests for liver toxicity would mean more medicines — and safer medicines — for patients http://www.thehamner.org/news-events/entry/better-tests-for-liver-toxicity-would-mean-more-medicines-and-safer-medicin Partnership to assess liver toxicity model http://www.thehamner.org/news-events/entry/partnership-to-assess-liver-toxicity-model Certara Teams up with the Hamner Institutes for Health Sciences to Explore Liver Toxicity http://www.thehamner.org/news-events/entry/certara-teams-up-with-the-hamner-institutes-for-health-sciences-to-explore Certara inks research agreement with the Hamner Institutes http://www.thehamner.org/news-events/entry/certara-inks-research-agreement-with-the-hamner-institutes Certara inks research deal to predict drugs’ impact on liver http://www.thehamner.org/news-events/entry/certara-inks-research-deal-to-predict-drugs-impact-on-liver Certara and The Hamner Institutes for Health Sciences form research partnership http://www.thehamner.org/news-events/entry/certara-and-the-hamner-institutes-for-health-sciences-form-research-partner Certara Signs Research Agreement with The Hamner Institutes for Health Sciences ST. LOUIS, MO – Aug. 20, 2013– Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, today announcedthat it has signed a research agreement with The Hamner Institutes for Health Sciences. Under this research agreement, Certara and The Hamner will explore the scientific benefits of using Certara’s Simcyp™ Simulator to drive hepatic drug exposure within The Hamner’s population-based, drug-induced liver injury (DILI) model. The partners plan to integrate The Hamner’s DILIsym® modeling software into Certara’s Simcyp Population-based Simulator and test the integrated product’s simulation capabilities with respect to drug exposure and resultant liver toxicity. Both of these systems are used by several leading international pharmaceutical companies. http://www.thehamner.org/news-events/entry/certara-signs-research-agreement-with-the-hamner-institutes-for-health-scie The Hamner Releases New DILIsym® Software Versions RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences (www.thehamner.org) announces the release of DILIsym® v2B and MITOsym™ v1A. DILIsym® and MITOsym™ software are developed and released as part of the DILI-sim Initiative (www.dilisym.com), an effort to develop a mathematical, mechanistic model of drug-induced liver injury chaired by Dr. Paul B. Watkins. DILIsym® v2B and MITOsym™ v1A were made available to all DILI-sim Initiative industry members as of July 24th, 2013. http://www.thehamner.org/news-events/entry/the-hamner-releases-dilisymv2b-and-mitosym-v1a Hepregen, Hamner Institutes sign research partnership agreement http://www.thehamner.org/news-events/entry/hepregen-hamner-institutes-sign-research-partnership-agreement The Hamner, Hepragen enter liver technology R&D partnership http://www.thehamner.org/news-events/entry/the-hamner-hepragen-enter-liver-technology-rd-partnership Hepregen Corporation and The Hamner Institutes Announce Research Partnership Agreement MEDFORD, Mass. & RESEARCH TRIANGLE PARK, N.C.-- August 6, 2013 -- Hepregen Corporation, developer of next generation HepatoPacTM and HepatoMuneTM products, and The Hamner Institutes for Health Sciences, a nonprofit research organization focused on translational safety sciences, announced today execution of an agreement that provides for a research partnership between the two entities. The research effort will be led by Dr. Edward LeCluyse, Associate Investigator at The Hamner, and Dr. Michael Holsapple, newly appointed Vice President of Toxicology Product Development at Hepregen, along with Mr. Jack McGeehan, Hepregen’s Vice President of Operations. The partnership will focus on research and development efforts aimed at defining: (1) basic concepts regarding the potential for new micro-liver products and (2) new applications and assay methodologies for Hepregen’s existing micro-liver products that are already transforming pharmaceutical product development. http://www.thehamner.org/news-events/entry/hepregen-corporation-and-the-hamner-institutes-for-health-sciences-announce Hepregen forges R&D partnership with Hamner Institutes of Health http://www.thehamner.org/news-events/entry/hepregen-forges-rd-partnership-with-hamner-institutes-of-health Teaming up to tackle pervasive pollutants http://www.thehamner.org/news-events/entry/teaming-up-to-tackle-pervasive-pollutants Michigan State University scientists to lead a $14.1 million initiative to study dioxins http://www.thehamner.org/news-events/entry/michigan-state-university-scientists-to-lead-a-141-million-initiative-to-s Dr. Alison Harrill to Speak at The Toxicology Forum http://www.thehamner.org/news-events/entry/alison-harrill-to-speak-at-the-toxicology-forum Dr. Miyoung Yoon to Present at XIII ICT 2013 Meeting http://www.thehamner.org/news-events/entry/miyoung-yoon-to-present-at-xiii-ict-2013-meeting Dr. Paul Watkins to Give Talk at Sino-American Symposium on Clinical and Translational Medicine http://www.thehamner.org/news-events/entry/paul-watkins-to-give-talk-at-sino-american-symposium-on-clinical-and-tr Drs. Thomas and Wetmore to Present at ICCA-LRI and NCATS Workshop http://www.thehamner.org/news-events/entry/thomas-and-wetmore-to-present-at-icca-lri-and-ncats-workshop IDSS Scientists to Highlight Drug Safety Conference at World Pharma Congress http://www.thehamner.org/news-events/entry/idss-scientists-to-highlight-drug-safety-conference-at-world-pharma-congres Dr. Melvin Andersen to Serve on Organizing Committee for FDA Workshop http://www.thehamner.org/news-events/entry/melvin-andersen-to-serve-on-organizing-committee-for-fda-workshop Dr. Paul Watkins to Speak at Hepatology 360 Conference http://www.thehamner.org/news-events/entry/paul-watkins-to-speak-at-hepatology-360-conference Dr. Russell Thomas to Speak at ILSI Health and Environmental Sciences Institute Conference http://www.thehamner.org/news-events/entry/russell-thomas-to-speak-at-ilsi-health-and-environmental-sciences-insti Dr. Melvin Andersen to Lead Course at Karolinska Institutet http://www.thehamner.org/news-events/entry/melvin-andersen-to-lead-course-at-karolinska-institutet Dr. Brett Howell to Present Poster at American Conference on Pharmacometrics http://www.thehamner.org/news-events/entry/brett-howell-to-present-poster-at-american-conference-on-pharmacometric Dr. Melvin Andersen to Co-Chair Session on Developing Microphysiological Systems http://www.thehamner.org/news-events/entry/melvin-andersen-to-co-chair-session-on-developing-microphysiological-sy Dr. Paul Watkins to Speak at Medical Grand Rounds http://www.thehamner.org/news-events/entry/paul-watkins-to-speak-at-medical-grand-rounds Joe Trask to Present at Perkin Elmer Global Health Summit http://www.thehamner.org/news-events/entry/joe-trask-to-present-at-perkin-elmer-global-health-summit The Hamner Releases DILIsym® v2A RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences (www.thehamner.org) announces the release of DILIsym® v2A. DILIsym® software is developed and released as part of the DILI-sim Initiative (www.dilisym.com), an effort to develop a mathematical, mechanistic model of drug-induced liver injury chaired by Dr. Paul B. Watkins. DILIsym® v2A was made available to all DILI-sim Initiative industry members as of April 10th, 2013. http://www.thehamner.org/news-events/entry/the-hamner-releases-dilisym-v2a